GSPRX
Price
$32.17
Change
-$0.19 (-0.59%)
Updated
Aug 19 closing price
Net Assets
1.39B
VTSMX
Price
$153.12
Change
-$0.93 (-0.60%)
Updated
Aug 19 closing price
Net Assets
1.91T
Interact to see
Advertisement

GSPRX vs VTSMX

Header iconGSPRX vs VTSMX Comparison
Open Charts GSPRX vs VTSMXBanner chart's image
Goldman Sachs Large Cap Equity R
Price$32.17
Change-$0.19 (-0.59%)
VolumeN/A
Net Assets1.39B
Vanguard Total Stock Mkt Idx I
Price$153.12
Change-$0.93 (-0.60%)
VolumeN/A
Net Assets1.91T
GSPRX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSPRX vs. VTSMX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSPRX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.91T vs. GSPRX (1.39B). VTSMX pays higher dividends than GSPRX: VTSMX (1.09) vs GSPRX (0.18). GSPRX was incepted earlier than VTSMX: GSPRX (18 years) vs VTSMX (33 years). GSPRX (1.38) is less costly to investors than VTSMX (0.14). GSPRX is a more actively managed with annual turnover of: 57.00 vs. VTSMX (2.00). GSPRX has a lower initial minimum investment than VTSMX: GSPRX (0) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 14.18 vs. GSPRX (2.25). VTSMX return over 5 years is better than : 83.88 vs. GSPRX (32.55).
GSPRXVTSMXGSPRX / VTSMX
Total Expense Ratio1.250.14893%
Annual Report Gross Expense Ratio1.380.14986%
Fund Existence18 years33 years-
Gain YTD9.3108.642108%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B1.91T0%
Annual Yield % from dividends0.181.0917%
Returns for 1 year2.2514.1816%
Returns for 3 years25.0748.9951%
Returns for 5 years32.5583.8839%
Returns for 10 years34.95219.5116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENSG167.022.96
+1.80%
Ensign Group (The)
YMAB8.52N/A
N/A
Y-mAbs Therapeutics
BKV21.34-0.09
-0.42%
BKV Corp
OPAL2.25-0.04
-1.75%
OPAL Fuels
CYCCP4.81-1.10
-18.61%
Cyclacel Pharmaceuticals